Patent Foramen Ovale on Transthoracic Echocardiography and Brain White-Matter Hyperintensities: A Transportability Analysis and Practice-Anchored Risk Framework
Authors:
- Andrey ArdashevAAAndrey Ardashev
- Jeremiah WasserlaufJWJeremiah Wasserlauf
- Kevin EstradaKEKevin Estrada
- Evgeny ZhelyakovEvgeny Zhelyakov
- Ariel StarrASAriel Starr
- Vyacheslav KolievVKVyacheslav Koliev
- Aleksey AmyagaAAAleksey Amyaga
- Evan DoubovikovEDEvan Doubovikov
- Arina ProkudinaAPArina Prokudina
- Viktor TcivkovskiiVTViktor Tcivkovskii
- Janna DoroshJDJanna Dorosh
Open Access
- 11 June 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4541
Abstract
Background: Meta-analyses suggest an association between patent foramen ovale (PFO) and white-matter hyperintensities (WMH), but pooled effect sizes do not clarify applicability to routine transthoracic echocardiography (TTE) or provide patient-level risk estimates. Objective: The objective of this study was to evaluate the association between TTE-detected PFO and MRI-defined WMH in routine practice and to develop a practice-anchored framework (PAMAP) that translates literature-derived evidence into individualized risk. Methods: We performed a retrospective, single-center, propensity-matched analysis of 149 adults undergoing TTE and brain MRI (37 PFO-positive, 112 controls). The primary endpoint was WMH (Fazekas ≥ 1). PAMAP synthesized 12 studies; 4 eligible studies were pooled using random-effects meta-analysis to derive a locked shunt coefficient (OR 3.65). The locked model used age and shunt (H); embolic context (E), and atrial stress (A) were neutral until refit. Transportability was assessed at the cohort level (expected vs. observed prevalence) and patient level (calibration, discrimination), followed by a minimal prespecified refit. Results: WMH was more frequent in PFO-positive versus control participants (54% vs. 32%). Literature-based expected prevalence approximated observed prevalence, supporting transportability. The locked model showed acceptable performance (calibration intercept 0.106; slope 0.912; Brier 0.188; AUC 0.756). A parsimonious refit improved performance (Brier 0.176; AUC 0.783), with the shunt term remaining significant (OR 2.45, 95% CI 1.23–4.88). Conclusions: PAMAP translates meta-analytic associations into a transportable patient-level risk framework. In routine TTE-defined PFO populations, the WMH association is preserved, suggesting that incidental PFO may mark early subclinical cerebral injury and enabling calibrated, individualized risk assessment.Keywords
This publication has 19 references indexed in Scilit:
- White matter lesions as a prognostic marker of recurrence in cryptogenic stroke with high-risk patent foramen ovaleJournal of Stroke and Cerebrovascular Diseases, 2024
- Different patterns of white matter lesions among patent foramen ovale, atherosclerotic cerebral small vessel disease and cerebral venous thrombosisJournal of Thrombosis and Thrombolysis, 2022
- White matter lesion characteristics on MRI can differentiate multiple sclerosis from patent foramen ovaleJournal of the Neurological Sciences, 2021
- Diastolic Dysfunction and the New Recommendations for Echocardiographic Assessment of Left Ventricular Diastolic Function: Summary of Guidelines and Novelties in Diagnosis and GradingJournal of Diagnostic Medical Sonography, 2019
- Imaging Characteristics of Ischemic Strokes Related to Patent Foramen OvaleStroke, 2013
- Diagnostic Value of Transthoracic Echocardiography for Patent Foramen Ovale: A Meta-analysisUltrasound in Medicine & Biology, 2013
- Patent Foramen Ovale, Subclinical Cerebrovascular Disease, and Ischemic Stroke in a Population-Based CohortJACC, 2013
- Silent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen OvaleStroke, 2009
- Patent Foramen Ovale Size and Embolic Brain Imaging Findings Among Patients With Ischemic StrokeStroke, 1998
- Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovaleBMJ, 1997